Related Experiment Video
Updated: May 4, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.3K
Primary carnitine deficiency and cardiomyopathy
Lijun Fu1, Meirong Huang1, Shubao Chen1
1Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Korean Circulation Journal
|January 4, 2014
Summary
Primary carnitine deficiency (PCD) impairs energy production from fatty acids, potentially causing severe heart problems. Early L-carnitine treatment is crucial for managing this rare, treatable metabolic disorder.
Area of Science:
- Biochemistry
- Genetics
- Cardiology
Background:
- Carnitine facilitates long-chain fatty acid transfer into mitochondria for beta-oxidation.
- Carnitine deficiency impairs energy production, particularly during metabolic stress.
- Primary carnitine deficiency (PCD) is a rare, inherited disorder affecting mitochondrial beta-oxidation.
Purpose of the Study:
- To review the pathophysiology, clinical presentation, diagnosis, and treatment of Primary Carnitine Deficiency.
- To highlight the cardiac manifestations and management of PCD.
- To emphasize the importance of early diagnosis and L-carnitine supplementation.
Main Methods:
- Literature review of primary carnitine deficiency.
- Analysis of clinical data and case studies.
- Synthesis of information on pathophysiology and treatment.
Main Results:
- PCD results from defective carnitine transport, impacting energy metabolism.
- Clinical presentations range from infantile metabolic decompensation to childhood cardiomyopathy.
- L-carnitine treatment is effective and potentially life-saving.
Conclusions:
- PCD is a treatable cause of metabolic cardiomyopathy.
- Early diagnosis and intervention with L-carnitine are critical for favorable outcomes.
- Understanding PCD's cardiac involvements is essential for patient management.
More Related Videos
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
01:21Myocarditis I: Introduction
645
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753